California Peptide Research产品代理
2025-07-31
California Peptide Research产品代理
金山科研平台代理微信：jinshanbioCalifornia Peptide Research提供客户的多肽合成定制服务，包括肥胖抑制素, β淀粉样肾脏髓质素肽, 内皮素, 内皮素拮抗剂。
California Peptide Research提供客户的多肽合成定制服务，包括肥胖抑制素, β淀粉样肾脏髓质素肽, 内皮素, 内皮素拮抗剂。
| a-Secretase Substrate | 1.0 mg | 165 |
| Acetyl-Arg-（Glu-Edans）-Val-His-His-Gln-Lys-Leu-Val-Phe-（Dabcyl-Lys）-Arg-OH | ||
| a-Secretase Substrate | 5.0 mg | 655 |
| Acetyl-Arg-（Glu-Edans）-Val-His-His-Gln-Lys-Leu-Val-Phe-（Dabcyl-Lys）-Arg-OH | ||
| Abarelix | 1.0 mg | 130 |
| Acetyl-（D-Naphtyl-Ala ）-（p-Chloro-D-Phenylalanine）-（Pyridyl-Ala）-Ser-（NMe-Tyr）-D-Asp-Leu-（Iso-Lys）-Pro-D-Ala-NH2 | ||
| Abarelix | 5.0 mg | 530 |
| Acetyl-（D-Naphtyl-Ala ）-（p-Chloro-D-Phenylalanine）-（Pyridyl-Ala）-Ser-（NMe-Tyr）-D-Asp-Leu-（Iso-Lys）-Pro-D-Ala-NH2 | ||
| Ac-Arg-Ala-Arg-AMC | 5.0 mg | 125 |
| Acetyl-Arg-Ala-Arg-AMC | ||
| Acetyl Beta Amyloid （25-35） | 1.0 mg | 55 |
| Acetyl-Gly-Ser-Asn-Lys-Gly-Ala-Ile-Ile-Gly-Leu-Met-OH | ||
| Acetyl Beta Amyloid （25-35） | 5.0 mg | 205 |
| Acetyl-Gly-Ser-Asn-Lys-Gly-Ala-Ile-Ile-Gly-Leu-Met-OH | ||
| Acetyl-Ala-Arg-AMC | 10.0 mg | 110 |
| Acetyl-Ala-Arg-AMC | ||
| Acetyl-Arg-Ala-Val-AMC | 5.0 mg | 110 |
| Acetyl-Arg-Ala-Val-AMC | ||
| Acetyl-Arg-Glu-Lys-Arg-AFC | 5.0 mg | 120 |
| Acetyl-Arg-Glu-Lys-Arg-AFC | ||
| Acetyl-Arg-Gly-Phe-Phe-Pro-AFC | 5.0 mg | 140 |
| Acetyl-Arg-Gly-Phe-Phe-Pro-AFC | ||
| Acetyl-Arg-Gly-Phe-Phe-Pro-AMC | 5.0 mg | 110 |
| Acetyl-Arg-Gly-Phe-Phe-Pro-AMC | ||
| Acetyl-Arg-Ser-Leu-Lys-AMC | 5.0 mg | 110 |
| Acetyl-Arg-Ser-Leu-Lys-AMC | ||
| Acetyl-Glu-Val-Asn-Leu-AFC | 5.0 mg | 120 |
| Acetyl-Glu-Val-Asn-Leu-AFC | ||
| Acetyl-Glu-Val-Asn-Leu-AMC | 5.0 mg | 110 |
| Acetyl-Glu-Val-Asn-Leu-AMC | ||
| Acetyl-Glu-Val-Asn-Leu-pNA | 5.0 mg | 90 |
| Acetyl-Glu-Val-Asn-Leu-pNA | ||
| Acetyl-Leu-Gln-Thr-Asp-AFC | 5.0 mg | 120 |
| Acetyl-Leu-Gln-Thr-Asp-AFC | ||
| Acetyl-Leu-Leu-Arg-AMC | 5.0 mg | 110 |
| Acetyl-Leu-Leu-Arg-AMC | ||
| Acetyl-Leu-Leu-Leu-AFC | 5.0 mg | 120 |
| Acetyl-Leu-Leu-Leu-AFC | ||
| Acetyl-Lys-Gln-Lys-Leu-Arg-4-methoxy-2-naphtylamide | 5.0 mg | 120 |
| Acetyl-Lys-Gln-Lys-Leu-Arg-4-methoxy-2-naphtylamide | ||
| Acetyl-Lys-Pro-Arg-AFC | 5.0 mg | 120 |
| Acetyl-Lys-Pro-Arg-AFC | ||
| Acetyl-Lys-Pro-Arg-AMC | 5.0 mg | 110 |
| Acetyl-Lys-Pro-Arg-AMC | ||
| Acetyl-Neurotensin （8-13） | 1.0 mg | 35 |
| Acetyl-Arg-Arg-Pro-Tyr-Ile-Leu-OH | ||
| Acetyl-Neurotensin （8-13） | 5.0 mg | 105 |
| Acetyl-Arg-Arg-Pro-Tyr-Ile-Leu-OH | ||
| Acetyl-Phe-Ile-Pro-Ala-Ser-Leu-Arg-AFC | 5.0 mg | 150 |
| Acetyl-Phe-Ile-Pro-Ala-Ser-Leu-Arg-AFC | ||
| Acetyl-Phe-Ser-Arg-pNA | 5.0 mg | 90 |
| Acetyl-Phe-Ser-Arg-pNA | ||
| Acetyl-Pro-Glu-Asp-Glu-AFC | 5.0 mg | 120 |
| Acetyl-Pro-Glu-Asp-Glu-AFC | ||
| Acetyl-Pro-Leu-Ser-Ser-Ile-Phe-Ser-Arg-Ile-Gly-Asp-Pro-Arg-Lys-Gly-Asp-Glu-Val-Asp-AFC | 5.0 mg | 185 |
| Acetyl-Pro-Leu-Ser-Ser-Ile-Phe-Ser-Arg-Ile-Gly-Asp-Pro-Arg-Lys-Gly-Asp-Glu-Val-Asp-AFC | ||
| Acetyl-Ser-Asp-Lys-Pro | 5.0 mg | 35 |
| Acetyl-Ser-Asp-Lys-Pro | ||
| Acetyl-Val-Glu-Ile-Ala-AFC | 5.0 mg | 120 |
| Acetyl-Val-Glu-Ile-Ala-AFC | ||
| ACTH （1-17） human | 1.0 mg | 80 |
| Ser-Tyr-Ser-Met-Glu-His-Phe-Arg-Trp-Gly-Lys-Pro-Val-Gly-Lys-Lys-Arg-OH | ||
| ACTH （1-17） human | 5.0 mg | 315 |
| Ser-Tyr-Ser-Met-Glu-His-Phe-Arg-Trp-Gly-Lys-Pro-Val-Gly-Lys-Lys-Arg-OH | ||
| ACTH （1-24）, human | 1.0 mg | 80 |
| Ser-Tyr-Ser-Met-Glu-His-Phe-Arg-Trp-Gly-Lys-Pro-Val-Gly-Lys-Lys-Arg-Arg-Pro-Val-Lys-Val-Tyr-Pro-OH | ||
| ACTH （1-24）, human | 5.0 mg | 315 |
| Ser-Tyr-Ser-Met-Glu-His-Phe-Arg-Trp-Gly-Lys-Pro-Val-Gly-Lys-Lys-Arg-Arg-Pro-Val-Lys-Val-Tyr-Pro-OH | ||
| ACTH （1-39）, rat | 1.0 mg | 205 |
| Ser-Tyr-Ser-Met-Glu-His-Phe-Arg-Trp-Gly-Lys-Pro-Val-Gly-Lys-Lys-Arg-Arg-Pro-Val-Lys-Val-Tyr-Pro-Asn-Val-Ala-Glu-Asn-Glu-Ser-Ala-Glu-Ala-Phe-Pro-Leu-Glu-Phe-OH | ||
| ACTH （7-38）, human / Corticotropin Inhibiting Peptide （7-38） | 1.0 mg | 120 |
| Phe-Arg-Trp-Gly-Lys-Pro-Val-Gly-Lys-Lys-Arg-Arg-Pro-Val-Lys-Val-Tyr-Pro-Asn-Gly-Ala-Glu-Asp-Glu-Ser-Ala-Glu-Ala-Phe-Pro-Leu-Glu-OH | ||
| ACTH （7-38）, human / Corticotropin Inhibiting Peptide （7-38） | 5.0 mg | 485 |
| Phe-Arg-Trp-Gly-Lys-Pro-Val-Gly-Lys-Lys-Arg-Arg-Pro-Val-Lys-Val-Tyr-Pro-Asn-Gly-Ala-Glu-Asp-Glu-Ser-Ala-Glu-Ala-Phe-Pro-Leu-Glu-OH | ||
| ADAM substrate | 1.0 mg | 230 |
| （Glu-EDANS）-Lys-Pro-Ala-Lys-Phe-Phe-Arg-Leu-（Dabcyl-Lys）-NH2 | ||
| ADAM substrate | 5.0 mg | 895 |
| （Glu-EDANS）-Lys-Pro-Ala-Lys-Phe-Phe-Arg-Leu-（Dabcyl-Lys）-NH2 | ||
| Adamantaneacetyl-[DArg0,Hyp3,Thi5,8,DPhe7] Bradykinin | 1.0 mg | 60 |
| Adamataneacetyl-D-Arg-Arg-Pro-Hyp-Gly-Thi-Ser-D-Phe-Thi-Arg-OH | ||
| Adamantaneacetyl-[DArg0,Hyp3,Thi5,8,DPhe7] Bradykinin | 5.0 mg | 210 |
| Adamataneacetyl-D-Arg-Arg-Pro-Hyp-Gly-Thi-Ser-D-Phe-Thi-Arg-OH | ||
| Adrenal Secretogranin, bovine | 5.0 mg | 155 |
| Phe-Pro-Lys-Pro-Ala-Gly-Ser-Gln-Asp-Lys-Pro-Leu-His-Asn-OH | ||
| Adrenomedullin （1-50）, rat | 0.5 mg | 310 |
| Tyr-Arg-Gln-Ser-Met-Asn-Gln-Gly-Ser-Arg-Ser-Thr-Gly-Cys-Arg-Phe-Gly-Thr-Cys-Thr-Met-Gln-Lys-Leu-Ala-His-Gln-Ile-Tyr-Gln-Phe-Thr-Asp-Lys-Asp-Lys-Asp-Gly-Met-Ala-Pro-Arg-Asn-Lys-Ile-Ser-Pro-Gln-Gly-Tyr-NH2 | ||
| Adrenomedullin （1-50）, rat | 1.0 mg | 500 |
| Tyr-Arg-Gln-Ser-Met-Asn-Gln-Gly-Ser-Arg-Ser-Thr-Gly-Cys-Arg-Phe-Gly-Thr-Cys-Thr-Met-Gln-Lys-Leu-Ala-His-Gln-Ile-Tyr-Gln-Phe-Thr-Asp-Lys-Asp-Lys-Asp-Gly-Met-Ala-Pro-Arg-Asn-Lys-Ile-Ser-Pro-Gln-Gly-Tyr-NH2 | ||
| Adrenomedullin （1-52）, human | 0.5 mg | 310 |
| Tyr-Arg-Gln-Ser-Met-Asn-Asn-Phe-Gln-Gly-Leu-Arg-Ser-Phe-Gly-Cys-Arg-Phe-Gly-Thr-Cys-Thr-Val-Gln-Lys-Leu-Ala-His-Gln-Ile-Tyr-Gln-Phe-Thr-Asp-Lys-Asp-Lys-Asp-Asn-Val-Ala-Pro-Arg-Ser-Lys-Ile-Ser-Pro-Gln-Gly-Tyr-NH2 | ||
| Adrenomedullin （1-52）, human | 1.0 mg | 500 |
| Tyr-Arg-Gln-Ser-Met-Asn-Asn-Phe-Gln-Gly-Leu-Arg-Ser-Phe-Gly-Cys-Arg-Phe-Gly-Thr-Cys-Thr-Val-Gln-Lys-Leu-Ala-His-Gln-Ile-Tyr-Gln-Phe-Thr-Asp-Lys-Asp-Lys-Asp-Asn-Val-Ala-Pro-Arg-Ser-Lys-Ile-Ser-Pro-Gln-Gly-Tyr-NH2 | ||
| Adrenomedullin （11-50）, rat | 0.5 mg | 230 |
| Ser-Thr-Gly-Cys-Arg-Phe-Gly-Thr-Cys-Thr-Met-Gln-Lys-Leu-Ala-His-Gln-Ile-Tyr-Gln-Phe-Thr-Asp-Lys-Asp-Lys-Asp-Gly-Met-Ala-Pro-Arg-Asn-Lys-Ile-Ser-Pro-Gln-Gly-Tyr-NH2 | ||
| Adrenomedullin （11-50）, rat | 1.0 mg | 395 |
| Ser-Thr-Gly-Cys-Arg-Phe-Gly-Thr-Cys-Thr-Met-Gln-Lys-Leu-Ala-His-Gln-Ile-Tyr-Gln-Phe-Thr-Asp-Lys-Asp-Lys-Asp-Gly-Met-Ala-Pro-Arg-Asn-Lys-Ile-Ser-Pro-Gln-Gly-Tyr-NH2 | ||
| Adrenomedullin （22-52）, human | 0.5 mg | 160 |
| Thr-Val-Gln-Lys-Leu-Ala-His-Gln-Ile-Tyr-Gln-Phe-Thr-Asp-Lys-Asp-Lys-Asp-Asn-Val-Ala-Pro-Arg-Ser-Lys-Ile-Ser-Pro-Gln-Gly-Tyr-NH2 | ||
| Adrenomedullin （22-52）, human | 1.0 mg | 240 |
| Thr-Val-Gln-Lys-Leu-Ala-His-Gln-Ile-Tyr-Gln-Phe-Thr-Asp-Lys-Asp-Lys-Asp-Asn-Val-Ala-Pro-Arg-Ser-Lys-Ile-Ser-Pro-Gln-Gly-Tyr-NH2 | ||
| Agatoxin IVa （ SS Cys 4,20 / Cys 12,25 / Cys 19,36 / Cys 27 | 0.5 mg | 835 |
| Lys-Lys-Lys-Cys-Ile-Ala-Lys-Asp-Tyr-Gly-Arg-Cys-Lys-Trp-Gly-Gly-Thr-Pro-Cys-Cys-Arg-Gly-Arg-Gly-Cys-Ile-Cys-Ser-Ile-Met-Gly-Thr-Asn-Cys-Glu-Cys-Lys-Pro-Arg-Leu-Ile-Met-Glu-Gly-Leu-Gly-Leu-Ala-OH | ||
| Agatoxin IVa （ SS Cys 4,20 / Cys 12,25 / Cys 19,36 / Cys 27 | 1.0 mg | 1525 |
| Lys-Lys-Lys-Cys-Ile-Ala-Lys-Asp-Tyr-Gly-Arg-Cys-Lys-Trp-Gly-Gly-Thr-Pro-Cys-Cys-Arg-Gly-Arg-Gly-Cys-Ile-Cys-Ser-Ile-Met-Gly-Thr-Asn-Cys-Glu-Cys-Lys-Pro-Arg-Leu-Ile-Met-Glu-Gly-Leu-Gly-Leu-Ala-OH | ||
| Akt Substrate | 5.0 mg | 105 |
| Arg-Pro-Arg-Ala-Ala-Thr-Phe-NH2 | ||
| All D Beta Amyloid （1-40）, human | 0.5 mg | 395 |
| D-Asp-D-Ala-D-Glu-D-Phe-D-Arg-D-His-D-Asp-D-Ser-Gly-D-Tyr-D-Glu-D-Val-D-His-D-His-D-Gln-D-Lys-D-Leu-D-Val-D-Phe-D-Phe-D-Ala-D-Glu-D-Asp-D-Val-Gly-D-Ser-D-Asn-D-Lys-Gly-D-Ala-D-Ile-D-Ile-Gly-D-Leu-D-Met-D-Val-Gly-Gly-D-Val-D-Val-OH | ||
| All D Beta Amyloid （1-40）, human | 1.0 mg | 685 |
| D-Asp-D-Ala-D-Glu-D-Phe-D-Arg-D-His-D-Asp-D-Ser-Gly-D-Tyr-D-Glu-D-Val-D-His-D-His-D-Gln-D-Lys-D-Leu-D-Val-D-Phe-D-Phe-D-Ala-D-Glu-D-Asp-D-Val-Gly-D-Ser-D-Asn-D-Lys-Gly-D-Ala-D-Ile-D-Ile-Gly-D-Leu-D-Met-D-Val-Gly-Gly-D-Val-D-Val-OH | ||
| Allatostatin B2, cockroach | 1.0 mg | 105 |
| Ala-Tyr-Ser-Tyr-Val-Ser-Glu-Tyr-Lys-Arg-Leu-Pro-Val-Tyr-Asn-Phe-Gly-Leu-NH2 | ||
| Alpha Atrial Natriuretic Polypeptide （1-28）, human / ANP （1- | 0.5 mg | 125 |
| Ser-Leu-Arg-Arg-Ser-Ser-Cys-Phe-Gly-Gly-Arg-Met-Asp-Arg-Ile-Gly-Ala-Gln-Ser-Gly-Leu-Gly-Cys-Asn-Ser-Phe-Arg-Tyr-OH | ||
| Alpha Atrial Natriuretic Polypeptide （1-28）, human / ANP （1- | 1.0 mg | 205 |
| Ser-Leu-Arg-Arg-Ser-Ser-Cys-Phe-Gly-Gly-Arg-Met-Asp-Arg-Ile-Gly-Ala-Gln-Ser-Gly-Leu-Gly-Cys-Asn-Ser-Phe-Arg-Tyr-OH | ||
| Alpha MSH Ac-Nle4 c[Asp5, D-Phe7, Lys10] （4-10） amide | 1.0 mg | 60 |
| Acetyl-050-Asp-His-011-Arg-Trp-Lys-NH2 | ||
| Alpha MSH Ac-Nle4 c[Asp5, D-Phe7, Lys10] （4-10） amide | 5.0 mg | 215 |
| Acetyl-050-Asp-His-011-Arg-Trp-Lys-NH2 | ||
| Alpha MSH [D-Phe7] | 1.0 mg | 60 |
| Acetyl-Ser-Tyr-Ser-Met-Glu-His-011-Arg-Trp-Gly-Lys-Pro-Val-NH2 | ||
| Alpha MSH [D-Phe7] | 5.0 mg | 215 |
| Acetyl-Ser-Tyr-Ser-Met-Glu-His-011-Arg-Trp-Gly-Lys-Pro-Val-NH2 | ||
| Alpha MSH [Nle4,D-Phe7] | 1.0 mg | 60 |
| Acetyl-Ser-Tyr-Ser-050-Glu-His-011-Arg-Trp-Gly-Lys-Pro-Val-NH2 | ||
| Alpha MSH [Nle4,D-Phe7] | 5.0 mg | 215 |
| Acetyl-Ser-Tyr-Ser-050-Glu-His-011-Arg-Trp-Gly-Lys-Pro-Val-NH2 | ||
| Alpha MSH, Ac-NLe4c[Asp5,DNal7,Lys10]（4-10） amide | 1.0 mg | 60 |
| Acetyl-050-Asp-His-038-Arg-Trp-Lys-NH2 | ||
| Alpha MSH, Ac-NLe4c[Asp5,DNal7,Lys10]（4-10） amide | 5.0 mg | 215 |
| Acetyl-050-Asp-His-038-Arg-Trp-Lys-NH2 | ||
| Amylin （1-37） NH2, human / Islet Amyloid Polypeptide （IAPP）, | 1.0 mg | 295 |
| Lys-Cys-Asn-Thr-Ala-Thr-Cys-Ala-Thr-Gln-Arg-Leu-Ala-Asn-Phe-Leu-Val-His-Ser-Ser-Asn-Asn-Phe-Gly-Ala-Ile-Leu-Ser-Ser-Thr-Asn-Val-Gly-Ser-Asn-Thr-Tyr-NH2 | ||
| Amylin （1-37） NH2, human / Islet Amyloid Polypeptide （IAPP）, | 5.0 mg | 1315 |
| Lys-Cys-Asn-Thr-Ala-Thr-Cys-Ala-Thr-Gln-Arg-Leu-Ala-Asn-Phe-Leu-Val-His-Ser-Ser-Asn-Asn-Phe-Gly-Ala-Ile-Leu-Ser-Ser-Thr-Asn-Val-Gly-Ser-Asn-Thr-Tyr-NH2 | ||
| Amylin （1-37） NH2, human / Islet Amyloid Polypeptide （IAPP）, | 10.0 mg | 2520 |
| Lys-Cys-Asn-Thr-Ala-Thr-Cys-Ala-Thr-Gln-Arg-Leu-Ala-Asn-Phe-Leu-Val-His-Ser-Ser-Asn-Asn-Phe-Gly-Ala-Ile-Leu-Ser-Ser-Thr-Asn-Val-Gly-Ser-Asn-Thr-Tyr-NH2 | ||
| Amylin, rat | 0.5 mg | 135 |
| Lys-Cys-Asn-Thr-Ala-Thr-Cys-Ala-Thr-Gln-Arg-Leu-Ala-Asn-Phe-Leu-Val-Arg-Ser-Ser-Asn-Asn-Leu-Gly-Pro-Val-Leu-Pro-Pro-Thr-Asn-Val-Gly-Ser-Asn-Thr-Tyr-NH2 | ||
| Amylin, rat | 1.0 mg | 230 |
| Lys-Cys-Asn-Thr-Ala-Thr-Cys-Ala-Thr-Gln-Arg-Leu-Ala-Asn-Phe-Leu-Val-Arg-Ser-Ser-Asn-Asn-Leu-Gly-Pro-Val-Leu-Pro-Pro-Thr-Asn-Val-Gly-Ser-Asn-Thr-Tyr-NH2 | ||
| Amyloid Blocker | 5.0 mg | 85 |
| Acetyl-Gln-Lys-Leu-Val-Phe-Phe-NH2 | ||
| Amyloid fragment （Pro18,Asp21） （17-21） | 5.0 mg | 105 |
| Leu-Pro-Phe-Phe-Asp-OH | ||
| Amyloid precursor | 1.0 mg | 135 |
| Mca-Ser-Glu-Val-Asn-Leu-Asp-Ala-Glu-Phe-Arg-（DNP-Lys）-Arg-Arg-NH2 | ||
| Amyloid precursor | 5.0 mg | 525 |
| Mca-Ser-Glu-Val-Asn-Leu-Asp-Ala-Glu-Phe-Arg-（DNP-Lys）-Arg-Arg-NH2 | ||
| Angiotensin Fragment （ 1-7 ） Acetate | 5.0 mg | 55 |
| Asp-Arg-Val-Tyr-Ile-His-Pro-OH | ||
| Angiotensin I [Asn1,Val5,Asn9], salmon | 1.0 mg | 30 |
| Asn-Arg-Val-Tyr-Val-His-Pro-Phe-Asn-Leu-OH | ||
| Angiotensin I [Asn1,Val5,Asn9], salmon | 5.0 mg | 105 |
| Asn-Arg-Val-Tyr-Val-His-Pro-Phe-Asn-Leu-OH | ||
| Angiotensin I [Val5,Asn9], bullfrog | 1.0 mg | 30 |
| Asp-Arg-Val-Tyr-Val-His-Pro-Phe-Asn-Leu-OH | ||
| Angiotensin I [Val5,Asn9], bullfrog | 5.0 mg | 105 |
| Asp-Arg-Val-Tyr-Val-His-Pro-Phe-Asn-Leu-OH | ||
| Angiotensin I/II （1-5） | 1.0 mg | 45 |
| Asp-Arg-Val-Tyr-Ile-OH | ||
| Angiotensin II [Sar1,Ile8] | 1.0 mg | 30 |
| 034-Arg-Val-Tyr-Ile-His-Pro-Ile-OH | ||
| Angiotensin II [Sar1,Ile8] | 5.0 mg | 100 |
| 034-Arg-Val-Tyr-Ile-His-Pro-Ile-OH | ||
| Angiotensin II, human | 5.0 mg | 35 |
| Asp-Arg-Val-Tyr-Ile-His-Pro-Phe-OH | ||
| Angiotensin II-[Sar1] | 5.0 mg | 80 |
| 034-Arg-Val-Tyr-Ile-His-Pro-Phe-OH | ||
| Angiotensin III, human） / Angiotensin II-[Des Asp1] | 10.0 mg | 55 |
| Arg-Val-Tyr-Ile-His-Pro-Phe-OH | ||
| Angiotensinogen （1-14） Renin Substrate （porcine） | 1.0 mg | 40 |
| Asp-Arg-Val-Tyr-Ile-His-Pro-Phe-His-Leu-Leu-Val-Tyr-Ser-OH | ||
| Angiotensinogen （1-14） Renin Substrate （porcine） | 10.0 mg | 185 |
| Asp-Arg-Val-Tyr-Ile-His-Pro-Phe-His-Leu-Leu-Val-Tyr-Ser-OH | ||
| ANP （123-150）, rat / ANP （6-33）, rat / ANP （1-28）, rat | 0.5 mg | 125 |
| Ser-Leu-Arg-Arg-Ser-Ser-Cys-Phe-Gly-Gly-Arg-Ile-Asp-Arg-Ile-Gly-Ala-Gln-Ser-Gly-Leu-Gly-Cys-Asn-Ser-Phe-Arg-Tyr-OH | ||
| ANP （123-150）, rat / ANP （6-33）, rat / ANP （1-28）, rat | 1.0 mg | 205 |
| Ser-Leu-Arg-Arg-Ser-Ser-Cys-Phe-Gly-Gly-Arg-Ile-Asp-Arg-Ile-Gly-Ala-Gln-Ser-Gly-Leu-Gly-Cys-Asn-Ser-Phe-Arg-Tyr-OH | ||
| ANP （126-150）, rat / Auriculin B, ANP （4-28）, rat | 0.5 mg | 125 |
| Arg-Ser-Ser-Cys-Phe-Gly-Gly-Arg-Ile-Asp-Arg-Ile-Gly-Ala-Gln-Ser-Gly-Leu-Gly-Cys-Asn-Ser-Phe-Arg-Tyr-OH | ||
| ANP （126-150）, rat / Auriculin B, ANP （4-28）, rat | 1.0 mg | 205 |
| Arg-Ser-Ser-Cys-Phe-Gly-Gly-Arg-Ile-Asp-Arg-Ile-Gly-Ala-Gln-Ser-Gly-Leu-Gly-Cys-Asn-Ser-Phe-Arg-Tyr-OH | ||
| ANP （4-24）, frog | 1.0 mg | 165 |
| Cys-Phe-Gly-Ser-Arg-Ile-Asp-Arg-Ile-Gly-Ala-Gln-Ser-Gly-Met-Gly-Cys-Gly-Arg-Arg-Phe-OH | ||
| ANP Des[18-22] （4-23） amide, rat | 1.0 mg | 125 |
| Arg-Ser-Ser-Cys-Phe-Gly-Gly-Arg-Ile-Asp-Arg-Ile-Gly-Ala-Cys-NH2 | ||
| Antennapedia Peptide | 1.0 mg | 80 |
| Arg - Gln - Ile - Lys - Ile - Trp - Phe - Gln - Asn - Arg - Arg - Met - Lys - Trp - Lys - Lys | ||
| Apamin, bee venom （SS1-11）（SS3-15） | 0.5 mg | 105 |
| Cys-Asn-Cys-Lys-Ala-Pro-Glu-Thr-Ala-Leu-Cys-Ala-Arg-Arg-Cys-Gln-Gln-His-NH2 | ||
| Apamin, bee venom （SS1-11）（SS3-15） | 1.0 mg | 160 |
| Cys-Asn-Cys-Lys-Ala-Pro-Glu-Thr-Ala-Leu-Cys-Ala-Arg-Arg-Cys-Gln-Gln-His-NH2 | ||
| APP （354-371） | 1.0 mg | 135 |
| Lys-Ala-Val-Ile-Gln-His-Phe-Gln-Glu-Lys-Val-Glu-Ser-Leu-Glu-Gln-Glu-Ala-OH | ||
| APP （354-371） | 5.0 mg | 525 |
| Lys-Ala-Val-Ile-Gln-His-Phe-Gln-Glu-Lys-Val-Glu-Ser-Leu-Glu-Gln-Glu-Ala-OH | ||
| APP Beta Secretase Inhibitor | 1.0 mg | 160 |
| Lys-Thr-Glu-Glu-Ile-Ser-Glu-Val-Asn-200-Val-Ala-Glu-Phe-OH | ||
| APP gamma secretase inhibitor | 5.0 mg | 60 |
| 3-5 difluorophenacetyl-Ala-217-t-Butylester | ||
| APP gamma secretase inhibitor | 5.0 mg | 60 |
| 3-5 difluorophenacetyl-Ala-（S-Phenylglycine）-Methylester | ||
| Arg-Glu（EDANS）-Glu-Val-Asn-Leu-Asp-Ala-Glu-Phe-（e-Dabcyl-Lysine）-Arg-OH | 1.0 mg | 135 |
| Arg-Glu（EDANS）-Glu-Val-Asn-Leu-Asp-Ala-Glu-Phe-（e-Dabcyl-Lysine）-Arg-OH | ||
| Arg-Leu-Lys-Gly-Gly-AFC | 5.0 mg | 140 |
| Arg-Leu-Lys-Gly-Gly-AFC | ||
| Asn-Ala-Pro-Val-Ser-Ile-Pro-Gln-OH | 5.0 mg | 120 |
| Asn-Ala-Pro-Val-Ser-Ile-Pro-Gln-OH | ||
| Asp-Glu-Val-Asp-AFC | 5.0 mg | 120 |
| Asp-Glu-Val-Asp-AFC | ||
| Atriopeptine III, rat;ANP （127-150）, rat | 0.5 mg | 115 |
| Ser-Ser-Cys-Phe-Gly-Gly-Arg-Ile-Asp-Arg-Ile-Gly-Ala-Gln-Ser-Gly-Leu-Gly-Cys-Asn-Ser-Phe-Arg-Tyr-OH | ||
| Atriopeptine III, rat;ANP （127-150）, rat | 1.0 mg | 185 |
| Ser-Ser-Cys-Phe-Gly-Gly-Arg-Ile-Asp-Arg-Ile-Gly-Ala-Gln-Ser-Gly-Leu-Gly-Cys-Asn-Ser-Phe-Arg-Tyr-OH | ||
| Autocamptide-2 Related Inhibitoy Peptide | 5.0 mg | 105 |
| Lys-Lys-Ala-Leu-Arg-Arg-Gln-Glu-Ala-Val-Asp-Ala-Leu-OH | ||
| Autocamptide-2 Related Inhibitoy Peptide | 5.0 mg | 105 |
| Myristoyl-Lys-Lys-Ala-Leu-Arg-Arg-Gln-Glu-Ala-Val-Asp-Ala-Leu-OH | ||
| BAM （6-22） Quote : 6920 | 0.5 mg | 125 |
| Arg-Arg-Val-Gly-Arg-Pro-Glu-Trp-Trp-Met-Asp-Tyr-Gln-Lys-Arg-Tyr-Gly-OH | ||
| BAM （6-22） Quote : 6920 | 1.0 mg | 185 |
| Arg-Arg-Val-Gly-Arg-Pro-Glu-Trp-Trp-Met-Asp-Tyr-Gln-Lys-Arg-Tyr-Gly-OH | ||
| BAM 3200 Bovine Adrenal Medulla Peptide E | 0.5 mg | 175 |
| Tyr-Gly-Gly-Phe-Met-Arg-Arg-Val-Gly-Arg-Pro-Glu-Trp-Trp-Met-Asp-Tyr-Gln-Lys-Arg-Tyr-Gly-Gly-Phe-Leu-OH | ||
| BAM 3200 Bovine Adrenal Medulla Peptide E | 1.0 mg | 290 |
| Tyr-Gly-Gly-Phe-Met-Arg-Arg-Val-Gly-Arg-Pro-Glu-Trp-Trp-Met-Asp-Tyr-Gln-Lys-Arg-Tyr-Gly-Gly-Phe-Leu-OH | ||
| Beta Amyloid （1-16） [Gln11], human | 0.5 mg | 60 |
| Asp-Ala-Glu-Phe-Arg-His-Asp-Ser-Gly-Tyr-Gln-Val-His-His-Gln-Lys-OH | ||
| Beta Amyloid （1-16） [Gln11], human | 1.0 mg | 85 |
| Asp-Ala-Glu-Phe-Arg-His-Asp-Ser-Gly-Tyr-Gln-Val-His-His-Gln-Lys-OH | ||
| Beta Amyloid （1-16） [Gln11], human | 5.0 mg | 320 |
| Asp-Ala-Glu-Phe-Arg-His-Asp-Ser-Gly-Tyr-Gln-Val-His-His-Gln-Lys-OH | ||
| Beta Amyloid （1-16）, rat | 1.0 mg | 90 |
| Asp-Ala-Glu-Phe-Gly-His-Asp-Ser-Gly-Phe-Glu-Val-Arg-His-Gln-Lys-OH | ||
| Beta Amyloid （1-16）, rat | 5.0 mg | 340 |
| Asp-Ala-Glu-Phe-Gly-His-Asp-Ser-Gly-Phe-Glu-Val-Arg-His-Gln-Lys-OH | ||
| Beta Amyloid （1-28）, [Gln11], human | 0.5 mg | 95 |
| Asp-Ala-Glu-Phe-Arg-His-Asp-Ser-Gly-Tyr-Gln-Val-His-His-Gln-Lys-Leu-Val-Phe-Phe-Ala-Glu-Asp-Val-Gly-Ser-Asn-Lys-OH | ||
© 金山科研平台是专业的授权总代理区域代理经销平台。
© 如需询价，请加客服QQ：1749072012 、客服微信：jinshanbio，或发送邮件到1749072012@qq.com
© 平台为生命科学研究相关领域提供一站式耗材试剂仪器解决方案和采购服务，数据资源基于CC协议。
© 本文地址：https://16ao.com/thread-217737.htm
© California Peptide Research产品代理，产品报价联系微信jinshanbio
© 如需询价，请加客服QQ：1749072012 、客服微信：jinshanbio，或发送邮件到1749072012@qq.com
© 平台为生命科学研究相关领域提供一站式耗材试剂仪器解决方案和采购服务，数据资源基于CC协议。
© 本文地址：https://16ao.com/thread-217737.htm
© California Peptide Research产品代理，产品报价联系微信jinshanbio
特别声明：以上内容(如有图片亦包括在内)来源于授权厂家或网络，如有侵权，请联系删除，本平台不提供信息存储服务。
Notice: The content above (including the pictures if any)comes from authorized manufacturers or networks. In case of infringement, please contact to delete it. This platform does not provide information storage services.
产品询价需求提交
猜你喜欢：
Bioworld巴傲得货号：BS2642-25ug
2025-07-22
CCK-8增值检测试剂盒、北京销售CCK-8增值检测试剂盒
2023-07-30
梅特勒快速水份测定仪HX204
2024-07-19
产品询价请加微信：jinshanbio
扫码添加客服微信，咨询产品报价
QQ:1749072012 为你推荐：